Charter Research Joins the Devana Solutions, LLC Platform and the Evolution of Metrics

Devana Solutions, LLC is always proud to partner with the brightest, most innovative minds in the clinical trials industry. This week we’re pleased to announce the addition of Charter Research to the game-changing Devana IGNITE platform. Charter Research is led by industry experts Jeff Pohlig, MBA and Jessica Sletten, MBA, two of the nation’s most highly regarded clinical trials executives. The Charter Research team is passionate about developing new therapies and breakthrough drugs so that people around the world can live better, healthier lives. We’re proud to continue our mission, supporting the backbone operations of work that envisions a better future for generations to come. clinicaltrials metrics clinicalresearch innovativetechnology



We Keep Growing! Meridien Research Joins Devana Solutions’ Innovative Platform.

Devana Solutions, LLC is committed to partnering with some of the world’s leading research sites to help shape the future of the clinical research industry. This week, Devana is pleased to announce the addition of Meridien Research and it’s affiliates to our growing subscriber-partner base. They’ve adopted Devana IGNITE for sites, a user-friendly software platform that simplifies the complex pipeline management process. IGNITE makes the management of business development, contact management, startup activities, study execution and performance metrics capture and analysis easier and faster.

By partnering with CROs and sponsors, Meridien Research study sites continue to be among the leaders in medical research and clinical trials in Florida. Meridien Research provides patients and families an opportunity to take part in clinical research trials for a wide variety of medical conditions. The professional teams at Meridien Research are experienced primarily in Phase Ib – Phase IV trials across a wide variety of therapeutic areas, including psychiatry, neurology, internal medicine, gastroenterology, OB/GYN, urology, cardiovascular risk-factors, endocrinology, and dermatology. Their studies across multiple locations in Central Florida, and its latest acquisition in Decatur, Georgia called NeuroStudies, help to further science and medicine.

It’s with great pride that we partner with another leading research site whose studies aid in the development of medical therapies that may offer better treatments, and even cures, for life-threatening and chronic diseases. We’re thrilled to welcome them aboard to help them drive better data, better decisions and better outcomes.